KRAS and neoplasm: With this in mind, our study aimed to evaluate the frequency of RAS mutations (including both KRAS and NRAS) and to investigate a possible association between these mutations and certain clinicopathological characteristics, as well as tumor localization, in a group of Bulgarian patients with mCRC.